Dr Sarah Byron is the Deputy Director for HealthTech and Programme Director for HealthTech Strategy and Development at NICE.
In this role, she works collaboratively with partners across the NHS and wider life science ecosystem to shape the HealthTech strategy at NICE and leads development projects that solve key challenges, balancing the needs of the NHS, patients and industry. Most recently, Sarah led the development of the National HealthTech Access Programme (rules-based pathway), the transformation of the NICE HealthTech programme, the development of the NICE and NHS England genomics pathway and established the new Early Value Assessment approach for health technologies that address key NHS needs, helping to build the evidence base for widespread adoption through early deployment in the NHS.
UK NSC works with the National Institute for Health and Care Excellence (NICE) and Health Improvement Scotland (HIS) to help improve early detection of health conditions.
Related content and links
About this blog
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.